Valuation: SenesTech, Inc.

Market Cap 8.32M 7.29M 6.72M 6.3M 11.8M 785M 12.05M 80.82M 31.27M 388M 31.24M 30.56M 1.35B P/E 2026 *
-1.07x
P/E 2027 * -1.27x
Enterprise Value 8.32M 7.29M 6.72M 6.3M 11.8M 785M 12.05M 80.82M 31.27M 388M 31.24M 30.56M 1.35B EV / Sales 2026 *
3.54x
EV / Sales 2027 * 1.85x
Free-Float
95.79%
Yield 2026 *
-
Yield 2027 * -
1 day+3.95%
1 week-4.24%
Current month-8.67%
1 month-11.73%
3 months-5.39%
6 months-31.90%
Current year-26.17%
1 week 1.44
Extreme 1.44
1.69
1 month 1.44
Extreme 1.44
1.77
Current year 1.41
Extreme 1.41
2.53
1 year 1.41
Extreme 1.41
6.24
3 years 1.3
Extreme 1.3
144
5 years 1.3
Extreme 1.3
4,608
10 years 1.3
Extreme 1.3
512,880.82
Manager TitleAgeSince
Chief Executive Officer 62 06/05/2026
Director of Finance/CFO 65 01/09/2015
Sales & Marketing - 01/01/2025
Director TitleAgeSince
Director/Board Member 54 08/01/2025
Director/Board Member 62 06/05/2026
Director/Board Member 51 05/07/2025
Date Insider Type Main position Quantity % Market Cap.
06-22
Glenbrook Capital Management
BuyCompany 5,000 0.0943%
06-15Free

Chairman

100,000 1.8856%
06-15Free

Director

100,000 1.8856%
Change 5-day change 1-year change 3-year change Capi.($)
+3.95%-4.24%-66.81%-98.87% 8.32M
+1.23%+5.13%+11.06%+45.10% 55.26B
+0.11%-.--%-.--%-.--% 12.96B
-3.17%-8.35%+69.09%+168.15% 11.35B
-4.09%+8.66%+43.18%+89.45% 8.61B
+0.80%-2.33%-25.63%-10.99% 6.48B
-1.16%+0.58%-8.32%+93.18% 6.1B
-1.47%-2.81%-8.40%-13.23% 5.29B
+0.02%-1.82%+20.37%+18.37% 4.7B
-2.33%-4.33%-35.39%-30.75% 4.32B
Average -0.61%-2.43%-0.09%+26.04% 11.51B
Weighted average by Cap. -0.19%+0.98%+12.59%+48.24%

Financials

2026 *2027 *
Net sales 2.35M 2.06M 1.9M 1.78M 3.33M 221M 3.4M 22.8M 8.82M 109M 8.81M 8.62M 380M 4.49M 3.94M 3.63M 3.4M 6.37M 423M 6.5M 43.61M 16.87M 209M 16.86M 16.49M 726M
Net income -7.83M -6.87M -6.33M -5.93M -11.11M -739M -11.34M -76.09M -29.44M -365M -29.41M -28.77M -1.27B -7.56M -6.63M -6.11M -5.72M -10.73M -713M -10.95M -73.47M -28.43M -353M -28.4M -27.78M -1.22B
Net Debt - -
Logo SenesTech, Inc.
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Employees
24
Date Price Change Volume
26/06/26 $1.580 +3.95% 34,103
25/06/26 $1.520 -2.56% 56,834
24/06/26 $1.560 -3.70% 39,502
23/06/26 $1.620 -5.26% 24,720
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.580USD
Average target price
6.750USD
Spread / Average Target
+327.22%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SNES Stock